Lipid tails modulate antimicrobial peptide membrane incorporation and activity
Affiliation
Department of Chemistry and Biochemistry, University of ArizonaBIO5 Institute, University of Arizona
Issue Date
2022-04
Metadata
Show full item recordPublisher
Elsevier BVCitation
Walker, L. R., & Marty, M. T. (2022). Lipid tails modulate antimicrobial peptide membrane incorporation and activity. Biochimica et Biophysica Acta - Biomembranes.Rights
© 2022 Elsevier B.V. All rights reserved.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Membrane disrupting antimicrobial peptides (AMPs) are often amphipathic peptides that interact directly with lipid bilayers. AMPs are generally thought to interact mostly with lipid head groups, but it is less clear how the lipid alkyl chain length and saturation modulate interactions with membranes. Here, we used native mass spectrometry to measure the stoichiometry of three different AMPs—LL-37, indolicidin, and magainin-2—in lipid nanodiscs. We also measured the activity of these AMPs in unilamellar vesicle leakage assays. We found that LL-37 formed specific hexamer complexes but with different intermediates and affinities that depended on the bilayer thickness. LL-37 was also most active in lipid bilayers containing longer, unsaturated lipids. In contrast, indolicidin incorporated to a higher degree into more fluid lipid bilayers but was more active with bilayers with thinner, less fluid lipids. Finally, magainin-2 incorporated to a higher degree into bilayers with longer, unsaturated alkyl chains and showed more activity in these same conditions. Together, these data show that higher amounts of peptide incorporation generally led to higher activity and that AMPs tend to incorporate more into longer unsaturated lipid bilayers. However, the activity of AMPs was not always directly related to amount of peptide incorporated.Note
12 month embargo; available online: 22 January 2022ISSN
0005-2736Version
Final accepted manuscriptSponsors
National Institutes of Healthae974a485f413a2113503eed53cd6c53
10.1016/j.bbamem.2022.183870